Matches in SemOpenAlex for { <https://semopenalex.org/work/W2328129558> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W2328129558 endingPage "167" @default.
- W2328129558 startingPage "158" @default.
- W2328129558 abstract "The efficacy and safety of doxazosin (DOX) for the treatment of hypertension was investigated. A multicenter, double-blind, placebo-controlled, parallel design was employed. A 4-week placebo runin period was followed by a 9-week double-blind period during which patients were randomly assigned to placebo or 2, 4, or 8 mg doxazosin. Blood pressures (BP) and heart rates (HR) were measured 24 hours postdose. The mean changes in standing BP (mmHg) were -6.2/-6.9 (2-mg regimen), -5.7/-5.8 (4-mg regimen), -8.5/-7.7 (8-mg regimen) for DOX patients and 0.7/-2.9 for placebo patients. The mean changes in supine BP (mmHg) were -3.2/-4.7 (2-mg regimen), -4.0/-5.1 (4-mg regimen), -4.6/-5.6 (8-mg regimen) for DOX patients and -0.5/-3.3 for placebo patients. There was no evidence of a dose-response relationship for DOX; however, DOX serum levels were linearly related to the dose. Responder rate for the combined DOX patients was 38% (32/84) and for the placebo patients 27% (8/30). HR (24 hours postdose) was not modified by DOX. Patients in the 8-mg regimen had a significantly higher gain in mean body weight (+ 1.3 +/- 0.3 kg; P less than 0.05) compared to the 2-mg regimen, 4-mg regimen, and placebo groups. Plasma norepinephrine was not significantly modified by DOX. DOX had a favorable effect on plasma lipids. DOX lowered LDL cholesterol (P less than 0.05), total cholesterol, and apoprotein B and increased HDL/(LDL + VLDL) ratio (0.05 less than or equal to P less than 0.1) compared to placebo. Dropout rate and treatment-related side effects were equally distributed among the DOX and placebo groups. No patients had the dose of medication reduced because of side effects. Three DOX patients were withdrawn because of postural dizziness." @default.
- W2328129558 created "2016-06-24" @default.
- W2328129558 creator A5001069191 @default.
- W2328129558 creator A5007818427 @default.
- W2328129558 creator A5026694473 @default.
- W2328129558 creator A5029958756 @default.
- W2328129558 creator A5033563716 @default.
- W2328129558 creator A5060750861 @default.
- W2328129558 creator A5066036850 @default.
- W2328129558 creator A5067569085 @default.
- W2328129558 date "1988-04-01" @default.
- W2328129558 modified "2023-10-16" @default.
- W2328129558 title "Effect of Doxazosin Monotherapy on Blood Pressure and Plasma Lipids in Patients with Essential Hypertension" @default.
- W2328129558 doi "https://doi.org/10.1093/ajh/1.2.158" @default.
- W2328129558 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2969740" @default.
- W2328129558 hasPublicationYear "1988" @default.
- W2328129558 type Work @default.
- W2328129558 sameAs 2328129558 @default.
- W2328129558 citedByCount "28" @default.
- W2328129558 countsByYear W23281295582012 @default.
- W2328129558 countsByYear W23281295582018 @default.
- W2328129558 countsByYear W23281295582019 @default.
- W2328129558 crossrefType "journal-article" @default.
- W2328129558 hasAuthorship W2328129558A5001069191 @default.
- W2328129558 hasAuthorship W2328129558A5007818427 @default.
- W2328129558 hasAuthorship W2328129558A5026694473 @default.
- W2328129558 hasAuthorship W2328129558A5029958756 @default.
- W2328129558 hasAuthorship W2328129558A5033563716 @default.
- W2328129558 hasAuthorship W2328129558A5060750861 @default.
- W2328129558 hasAuthorship W2328129558A5066036850 @default.
- W2328129558 hasAuthorship W2328129558A5067569085 @default.
- W2328129558 hasConcept C125567185 @default.
- W2328129558 hasConcept C126322002 @default.
- W2328129558 hasConcept C126894567 @default.
- W2328129558 hasConcept C142724271 @default.
- W2328129558 hasConcept C204787440 @default.
- W2328129558 hasConcept C27081682 @default.
- W2328129558 hasConcept C2776694085 @default.
- W2328129558 hasConcept C2777097880 @default.
- W2328129558 hasConcept C2777590997 @default.
- W2328129558 hasConcept C2781413609 @default.
- W2328129558 hasConcept C42219234 @default.
- W2328129558 hasConcept C71924100 @default.
- W2328129558 hasConcept C84393581 @default.
- W2328129558 hasConcept C98274493 @default.
- W2328129558 hasConceptScore W2328129558C125567185 @default.
- W2328129558 hasConceptScore W2328129558C126322002 @default.
- W2328129558 hasConceptScore W2328129558C126894567 @default.
- W2328129558 hasConceptScore W2328129558C142724271 @default.
- W2328129558 hasConceptScore W2328129558C204787440 @default.
- W2328129558 hasConceptScore W2328129558C27081682 @default.
- W2328129558 hasConceptScore W2328129558C2776694085 @default.
- W2328129558 hasConceptScore W2328129558C2777097880 @default.
- W2328129558 hasConceptScore W2328129558C2777590997 @default.
- W2328129558 hasConceptScore W2328129558C2781413609 @default.
- W2328129558 hasConceptScore W2328129558C42219234 @default.
- W2328129558 hasConceptScore W2328129558C71924100 @default.
- W2328129558 hasConceptScore W2328129558C84393581 @default.
- W2328129558 hasConceptScore W2328129558C98274493 @default.
- W2328129558 hasIssue "2" @default.
- W2328129558 hasLocation W23281295581 @default.
- W2328129558 hasLocation W23281295582 @default.
- W2328129558 hasOpenAccess W2328129558 @default.
- W2328129558 hasPrimaryLocation W23281295581 @default.
- W2328129558 hasRelatedWork W1966898087 @default.
- W2328129558 hasRelatedWork W2013627905 @default.
- W2328129558 hasRelatedWork W2052122168 @default.
- W2328129558 hasRelatedWork W2060356482 @default.
- W2328129558 hasRelatedWork W2084535212 @default.
- W2328129558 hasRelatedWork W2088257251 @default.
- W2328129558 hasRelatedWork W2119301592 @default.
- W2328129558 hasRelatedWork W2154813402 @default.
- W2328129558 hasRelatedWork W2328129558 @default.
- W2328129558 hasRelatedWork W2471646660 @default.
- W2328129558 hasVolume "1" @default.
- W2328129558 isParatext "false" @default.
- W2328129558 isRetracted "false" @default.
- W2328129558 magId "2328129558" @default.
- W2328129558 workType "article" @default.